Guangdong Imvin Pharmaceutical

Guangdong Imvin Pharmaceutical is a China-based pharmaceutical company focused on the research, development, and commercialization of high-quality generic and innovative medicines. The company specializes in therapeutic areas such as metabolic diseases, cardiovascular health, and chronic disease management. Imvin Pharmaceutical operates integrated facilities for R&D and large-scale manufacturing, adhering to Good Manufacturing Practice (GMP) standards. Its product portfolio includes treatments for hypertension, hyperlipidemia, and type 2 diabetes, aiming to provide affordable and effective healthcare solutions to the Chinese market. The company continues to expand its pipeline through both internal development and strategic collaborations.